Iris Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-16
Clinical Trial Update: Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma [Phase 2]
Phase 2 clinical trial update evaluating sunitinib malate or valproic acid to prevent metastasis in high-risk uveal melanoma.